VEGF

Title	Average Rating
Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor acti	90.00%
ROS production and angiogenic regulation by macrophages in response to heat therapy.	80.00%
Tissue factor, angiogenesis and thrombosis in pancreatic cancer.	60.00%
Serum cytokines in pancreatic cancer: Correlation with outcome	40.00%
A phase II study of two dosing regimens of GSK 1363089 (GSK089), a dual MET/VEGFR2 inhibitor, in patients (pts) with papillar...	30.00%

Languages